National Institute on Drug Abuse; Notice of Closed Meeting, 1338-1339 [07-77]
Download as PDF
<![CDATA[
1338
Federal Register / Vol. 72, No. 7 / Thursday, January 11, 2007 / Notices
Dental & Craniofacial Research, National
Institutes of Health, Bethesda, MD 20892,
(301) 594–4827, kims@email.nidr.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 07–40, Review R21.
Date: March 6, 2007.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Lynn M. King, PhD,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., Rm 4AN–32F,
National Institute of Dental & Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892–6402, 301–594–5006,
lynn.king@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 07–29, Review R21s.
Date: March 9, 2007.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Lynn M. King, PhD,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., Rm 4AN–32F,
National Institute of Dental & Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892–6402, 301–594–5006,
lynn.king@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 3, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–73 Filed 1–10–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
cprice-sewell on PROD1PC66 with NOTICES
National Institute on Drug Abuse,
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Aug<31>2005
15:52 Jan 10, 2007
Jkt 211001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Centers
Review Committee.
Date: February 19, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401,
301.435.1388, rliu@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel Program
Projects.
Date: February 20, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401,
301.435.1388, rliu@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group,
Medication Development Research
Subcommittee.
Date: March 5, 2007.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott at Metro Center, 775 12th
Street, NW., Washington, DC 20005.
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Blvd, Bethesda, MD
20892–8401, 301–402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Health
Services Research Subcommittee.
Date: March 6–7, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Meenaxi Hiremath, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6101 Executive Blvd., Suite 220, MSC
8401, Bethesda, MD 20892, 301–402–7964,
mh392g@nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Treatment
Research Subcommittee.
Date: March 6–7, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Kesinee Nimit, MD, Health
Scientist Administrator, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, Md 20892–
8401, (301) 435–1432.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Training
and Career Development Subcommittee.
Date: March 13–15, 2007.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Eliane Lazar-Wesley, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6101 Executive
Boulevard, Room 220, MS 8401, Bethesda,
MD 20892–8401, 301–451–4530,
el6r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 3, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–76 Filed 1–10–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Technical Support for Constituency Outreach
and Research Dissemination.
Date: February 1, 2007.
Time: 9:30 a.m. to 11:30 p.m.
Agenda: To review and evaluate contract
proposals.
E:\FR\FM\11JAN1.SGM
11JAN1
Federal Register / Vol. 72, No. 7 / Thursday, January 11, 2007 / Notices
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 3, 2007.
Anna M. Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–77 Filed 1–10–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Surgery,
Anesthesiology and Trauma Study
Section, January 24, 2007, 8 a.m. to
January 25, 2007, 5 p.m., Holiday Inn
Georgetown, 2101 Wisconsin Avenue,
NW., Washington, DC 20007 which was
published in the Federal Register on
December 5, 2006, 71 FR 70522–70523.
The meeting will be held January 24,
2007, 1 p.m. to January 25, 2007, 1 p.m.
The meeting dates and location remain
the same. The meeting is closed to the
public.
Dated: January 3, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–75 Filed 1–10–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
cprice-sewell on PROD1PC66 with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Aug<31>2005
15:52 Jan 10, 2007
Jkt 211001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Gene
Regulation in Cell Death and Psychiatric
Disorders.
Date: January 8, 2007.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Carol Hamelink, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5040H,
MSC 7850, Bethesda, MD 20892, (301) 451–
1328, hamelinc@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Computational Anatomy and
Multidimensional Modeling.
Date: January 21–23, 2007.
Time: 7 p.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: The Westwood on Wilshire Hotel,
10740 Wilshire Boulevard, Los Angeles, CA
90024.
Contact Person: Lee Rosen, PhD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 5116, MSC 7854,
Bethesda, MD 20892, (301) 435–1171,
rosenl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Wound
Healing.
Date: January 25, 2007.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Weihua Luo, MD, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Parasites.
Date: January 26, 2007.
Time: 1:30 p.m. to 2 p.m.
Agenda: To review and evaluate grant
application, National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Fouad A. el-Zaatari, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
MSC 7808, Bethesda, MD 20814–9692, (301)
435–1149, elzaataf@csr.nih.gov.
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
1339
Name of Committee: Oncological Sciences
Integrated Review Group, Basic Mechanisms
of Cancer Therapeutics Study Section.
Date: January 29–30, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Suzanne L. ForrySchaudies, PhD, Scientific Review
Administrator, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6192, MSC 7804, Bethesda, MD
20892, (301) 451–0131, forryscs@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group, Biomaterials and Biointerfaces Study
Section.
Date: February 1–2, 2007.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Hotel, 8120 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Alexander Gubin, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4196,
MSC 7812, Bethesda, MD 20892, (301) 435–
2902, gubina@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group,
Skeletal Biology Structure and Regeneration
Study Section.
Date: February 4–7, 2007.
Time: 8 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate. 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Mehrdad M. Tondravi,
PhD, Scientific Review Administrator, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, (301) 435–
1173, tondravm@csr.nih.gov.
Name of Committee: Digestive Sciences
Integrated Review Group, Gastrointestinal
Mucosal Pathobiology Study Section.
Date: February 5, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott—Embassy
Row, 1600 Rhode Island Ave, NW.,
Washington, DC 20036.
Contact Person: Peter J. Perrin, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Cognitive
Neuroscience Study Section.
Date: February 6–7, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Hotel, 8120 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Michael A. Steinmetz,
PhD, Scientific Review Administrator, Center
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 72, Number 7 (Thursday, January 11, 2007)]
[Notices]
[Pages 1338-1339]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-77]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Technical Support for Constituency Outreach and
Research Dissemination.
Date: February 1, 2007.
Time: 9:30 a.m. to 11:30 p.m.
Agenda: To review and evaluate contract proposals.
[[Page 1339]]
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: January 3, 2007.
Anna M. Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-77 Filed 1-10-07; 8:45 am]
BILLING CODE 4140-01-M
